Serotonin Uptake InhibitorsSerotoninFluoxetineCitalopramParoxetineSerotonin Plasma Membrane Transport ProteinsAntidepressive Agents, Second-GenerationAntidepressive AgentsAntidepressive Agents, TricyclicFluvoxamineSertralineReceptors, SerotoninReceptor, Serotonin, 5-HT1ASerotonin AntagonistsReceptor, Serotonin, 5-HT2ASerotonin SyndromeCyclohexanolsReceptors, Serotonin, 5-HT1Serotonin Receptor AgonistsAdrenergic Uptake InhibitorsReceptor, Serotonin, 5-HT1BSerotonin AgentsReceptors, Serotonin, 5-HT2Depressive DisorderSerotonin 5-HT2 Receptor AntagonistsClomipramineDepressive Disorder, MajorTryptophan HydroxylaseSerotonin 5-HT1 Receptor AntagonistsReceptor, Serotonin, 5-HT2CReceptor, Serotonin, 5-HT2BSerotonergic NeuronsSerotonin 5-HT1 Receptor AgonistsNeurotransmitter Uptake InhibitorsRaphe NucleiDesipramine8-Hydroxy-2-(di-n-propylamino)tetralinObsessive-Compulsive DisorderPremenstrual SyndromeDepression1-NaphthylamineMaprotilineLofepramineDothiepinBehavior, AnimalReceptors, Serotonin, 5-HT3FenfluramineNorepinephrine Plasma Membrane Transport ProteinsSerotonin 5-HT2 Receptor AgonistsHydroxyindoleacetic Acid5-HydroxytryptophanReceptors, Serotonin, 5-HT4Anti-Anxiety AgentsMonoamine Oxidase InhibitorsBiogenic MonoaminesMianserinDrug InteractionsMicrodialysisRats, Sprague-Dawley5,7-DihydroxytryptamineDose-Response Relationship, DrugSerotonin 5-HT4 Receptor AgonistsFenclonineImipramineBrainAnxiety DisordersSwimmingAmitriptylineSuicideToxicity Tests, SubacutePiperazinesDouble-Blind MethodPsychiatric Status Rating ScalesTreatment OutcomeDepressive Disorder, Treatment-ResistantCognitive TherapyMembrane Transport ProteinsAnxietyNorepinephrineNortriptylinePregnancy ComplicationsDopamineAntipsychotic AgentsAutoreceptorsMotor ActivityKetanserinDopamine Uptake InhibitorsMoclobemidePanic DisorderAnalysis of VariancePatient DropoutsSexual Dysfunction, PhysiologicalMonoamine OxidaseTrazodoneDopamine Plasma Membrane Transport ProteinsTime FactorsCyclopropanesBupropionPhenelzinePregnancy Trimesters